Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment.
Siri A EikelandKnut B SmelandVictoria Charlotte SimensenUnn-Merete FagerliHanne S BersvendsenCecilie E KiserudAlexander FossåPublished in: Acta oncologica (Stockholm, Sweden) (2023)
After risk-adapted treatment, CF is still a frequent LE among long-term HLS, without apparent association with disease or treatment-related parameters. CF is associated with reduced WA and SES. As no apparent risk reduction is seen with contemporary treatment, further studies should emphasize etiological factors of CF and treatment to alleviate this common LE.